Coronary disease & ACSRandomised controlled trial
i-CARE: a smartphone-based intervention to enhance cardiac rehabilitation in coronary artery disease—a randomized controlled trial
- Randomised controlled trial
- assessor-blinded
- two-arm
- two regional hospitals in Hong Kong
Authors' conclusion
Remotely delivered i-CARE intervention effectively promote self-care among CAD patients and may help address critical healthcare workforce shortages, while also conferring secondary benefits in blood pressure and HRQoL.
Study context
- Population
- Community-dwelling adults with angiographically confirmed coronary artery disease (CAD)randomized
- Participants
- 294 adults
- Comparison
- i-CARE smartphone self-care support vs standard care
- i-CAREn = 147
- Standard caren = 147reference
- Primary endpoint
- Change in CAD self-care behaviours
- Follow-up
- 3 months
Primary result
As reported in the abstract
Self-care behaviours
- self-care maintenance
- β 4.055 (95% CI 1.420–6.691); P = 0.003
- self-care confidence
- β 5.609 (95% CI 1.089–10.129); P = 0.015
Secondary outcomes
BP and health-related quality of life (HRQoL) · 3 months
- SBP reduction with the intervention, β (95% CI), P
- −3.725 (−7.322 to −0.128), P = 0.042
- DBP reduction with the intervention, β (95% CI), P
- −2.153 (−4.228 to −0.079), P = 0.042
- HRQoL improvement with the intervention, β (95% CI), P
- 0.208 (0.073-0.343), P = 0.003
- benefits for DBP and HRQoL sustained at 6 months
Cardiac-specific health status, blood glucose, lipid profile, waist-to-height ratio
- No significant differences
Original publication
i-CARE: a smartphone-based intervention to enhance cardiac rehabilitation in coronary artery disease—a randomized controlled trial. Eur J Prev Cardiol. Published 11 August 2025. doi:10.1093/eurjpc/zwaf509
Summarised from the published abstract; every number is checked against it